Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Mayoh

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Nature Communications|July 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesisJayne E Murray, Emanuele Valli, Giorgio Milazzo, et al.
Nature Medicine|June 6, 2024
Precision-guided treatment in high-risk pediatric cancersLoretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Genome Medicine|April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancerChelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancerNoemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Cell Reports|November 7, 2019
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial DesignJo Lynne Rokita, Komal S Rathi, Maria F Cardenas, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Nature Communications|July 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesisJayne E Murray, Emanuele Valli, Giorgio Milazzo, et al.
Nature Medicine|June 6, 2024
Precision-guided treatment in high-risk pediatric cancersLoretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Genome Medicine|April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancerChelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancerNoemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Cell Reports|November 7, 2019
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial DesignJo Lynne Rokita, Komal S Rathi, Maria F Cardenas, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 10